Summary from listing
The role leads a multidisciplinary team advancing next-generation tumor-infiltrating lymphocyte (TIL) therapies by reprogramming and optimizing TILs through media, pharmacologic, and gene-engineering strategies. Responsibilities include process innovation, preclinical development, IND documentation, cross-functional collaboration, and mentoring, with a focus on translating mechanistic discoveries into scalable, clinically translatable candidates. The position requires a Ph.D. in a relevant field, postdoctoral training, and more than 10 years of hands-on experience in TIL biology, T cell immunology, genetic engineering, CRISPR screening, molecular biology, mouse models, and clinical translation.
